DescriptionSmall Molecule Drugs for the Treatment of Myotonic Dystrophy Type 1 (DM1).png
English: Lead compounds for the treatment of Myotonic Dystrophy Type 1 (DM1) that recognize r(CUG)exp repeats in cells and effect phenotypic outcomes consistent with the disease. PDB: 3GM7
to share – to copy, distribute and transmit the work
to remix – to adapt the work
Under the following conditions:
attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
share alike – If you remix, transform, or build upon the material, you must distribute your contributions under the same or compatible license as the original.